Two drugs packed into tiny fat bubbles were tested on glioma cells and in mice
Original title: Cannabidiol- and Celecoxib-Loaded Liposomes as a Strategy to Modulate Redox and Inflammatory Signaling in High-Grade Glioma: A Preliminary In Vivo Study.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done in animals, not people. Most findings at this stage never become treatments.
This was only done in lab cells and in mice.
The short version
This was an early lab and mouse test, not a treatment people can get.
What was studied. Researchers packed two drugs, cannabidiol (CBD) and celecoxib, into tiny fat bubbles called liposomes. They tested them on high grade glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are graded 1 to 4 by how fast they tend to grow. See the glossary cells in a dish, and in mice with tumors grown under the skin.
What they found. The bubbles raised harmful oxygen molecules inside the cells by 1.8-fold. One type of bubble, called cationic, killed up to 39% of the tumor cells. In the mice, the mix of both drugs showed a trend toward slower tumor growth.
What this means, and what it doesn't
What it could mean: This is a very early step. It suggests this drug mix may be worth studying further. It does not change care for people with brain tumors today.
What it doesn't mean: This does not mean CBD or celecoxib treat brain tumors in people. The work was done in cells and in mice, not in patients. The mouse part was small and preliminary, the drug was injected straight into the tumor, and the tumors grew under the skin instead of in the brain. The researchers say more studies are needed before anyone knows if this could help people. This is not a cure.
Source: PubMed, July 12, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.